Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Triple Negative Breast Neoplasms 1 Locally Advanced HER2-negative Breast Cancer 1 Hyperthermia 1

Interventions

Diathermy 20 Radiotherapy 11 Fluorouracil 4 Drug Therapy 4 Cisplatin 4 Radiation 3 Immune Checkpoint Inhibitors 3 Brachytherapy 3 tislelizumab 2 Surgical Procedures, Operative 2 Solutions 2 Immunotherapy 2 Hyperthermia, Induced 2 Hydrogen Peroxide 2 Conization 2 Capecitabine 2 spartalizumab 1 anlotinib 1 Temozolomide 1 Saline Solution 1 Radiation Dose Hypofractionation 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Oxaliplatin 1 Mitomycin 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Gemcitabine 1 Folfox protocol 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperthermia × AC protocol × Clear all

NCT05889390 2026-05-15

NeoHTerMa

Semmelweis University

Phase 2/3 Active not recruiting

Hyperthermia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡